Sheffield Institute for
Translational Neuroscience

Dr Laura Ferraiuolo PhD

Dr Laura Ferraiuolo
Lecturer in Translational Neurobiology,
University of Sheffield

Research Interests

The main research focus of my research group is identifying the role of glia in neurodegenerative conditions, with particular interest in motor neuron disease (MND). Our primary aim is to develop therapeutic strategies using gene therapy approaches.

In MND, like in many other neurodegenerative disorders, neuronal damage and death are the most striking signs of disease, however, our research, along with the work of others, has demonstrated that glia play an active role in neuronal degeneration.

We use various in vitro cell models, including primary cells and genetically reprogrammed human progenitor cells, to investigate the interaction between astrocytes and oligodendrocytes from patients affected by MND with neurons.   

The main research tools and techniques used in my laboratory:

1. Human astrocytes, oligodendrocytes and neurons derived from fibroblasts through genetic reprogramming

2. Mouse stem cells expressing the green fluorescent protein under the Hb9 promoter, resulting in GFP+ motor neurons (gift from Prof. Tom Jessell)

3. 2D and 3D Co-culture system to study the interaction between glia, neurones and other cell types

4. Viral constructs to target specific therapeutic candidates for gene therapy approaches

5. Gene expression profiling

6. High-throughput drug screening

Current Projects

1. The role of oxidative stress in astrocyte toxicity against motor neurones in MND: a drug screening for Nrf2 activators

2. A high-throughput drug screening to identify novel therapeutic targets to silence astrocyte toxicity in MND via small chemical compounds or gene therapy approaches

3. Identifying the role of oligodendrocytes in motor neurone injury in MND

4. Metabolic dysregulation in astrocytes derived from Parkin-mutant patients

My research group is also involved in several internal collaborations with other PIs within SITraN as well as international collaborations in the USA, Australia, Italy and Israel.

Our funders:

The Saudi Arabian Cultural Bureau

The Motor Neurone Disease Association

Parkinson’s UK

Marie Curie Fellowships

 Funders LF.png

Research Team

Dr Sufana Al Mashhadi, PhD

SM.jpg

 "I first arrived in Sheffield to do my MSc ​in Molecular Medicine in 2009 ​working on​ ​a zebrafish SOD1 model with Dr. T. Ramesh. Soon after starting my MSc, I realised my passion for neurodenerative disorders and I decided to pursue a PhD. I joined the neuropathology group lead by Prof. S. Wharton and Prof. P. Ince where I studied the changes associated with dementia and depression in the human ageing brain. I am now working as a Post-doctoral researcher with Dr Ferraiuolo investigating the role of oxidative stress in MND using cutting edge technique, including human cell models and stem cells".


Miss Monika A Myszczynska (lab technician)

Monika Muszynsky.jpg

 

"I graduated from Keele University in 2013 with a BSc (dual hons) in English and Neuroscience and obtained an MSc in Neuroscience Research in 2014. Previously worked as a research assistant at Albert-Ludwigs University of Freiburg on a project investigating the role of neuropoietic cytokines on adult murine neural stem cells, with a focus on JAK-STAT pathway inhibition."

 

 

 

 MSc Students

  • Tobias A Moll
  • Robert P Chard
  • Brendan B O'Neill

Publications

Selected Publications

  1. SW Song, CJ Miranda, L Braun, K Meyer,AE Frakes, L Ferraiuolo, S Likhite, AK Bevan, KD Foust, Michael J. McConnell, Christopher M. Walker, Brian K. Kaspar. Sustained expression of MHC class I protects motor neurons from ALS astrocyte-induced toxicity.In press Nature Medicine, 2015.

  2. S Sun, Y Sun, S Ling, L Ferraiuolo, M McAlonis-Downes, Y Zou, K Drenner, Y Wang, D Ditsworth, S Tokunaga, A Kopelevich, BK Kaspar, C Lagier-Tourenne, and DW Cleveland. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. PNAS, 2015 Nov 30. pii: 201520639.

  3. K Meyer*, L Ferraiuolo*, L Schmelzer, O Michels, V McGovern, L Braun, S Likhite, P Morales, J Ebel, K Foust, A Burghes, BK. Kaspar. Improving CSF delivery of AAV9-mediated gene therapy for SMA – a dose response study in mice and nonhuman primates. Mol Ther. 2014 Oct 31. *Equal contribution.

  4. L Ferraiuolo. The non-cell-autonomous component of ALS: new in vitro models and future challenges. Biochemical Society Transactions, September 2014, Vol. 42, No. 5, Pages 1270-1274.

  5. AE Frakes, L Ferraiuolo, AM Haidet-Phillips, L Schmelzer , L Braun, CJ Miranda, A Bevan, KD Foust, JP Godbout, PG Popovich, DC Guttridge, BK Kaspar. Microglia induce motor neuron death via the classical NF-κB pathway in inherited Amyotrophic Lateral Sclerosis. Neuron 2014 Mar 5;81(5):1009-23.

  6. K Meyer, L Ferraiuolo, CJ Miranda, S Likhite, S McElroy, S Renusch, D Ditsworth, C Lagier-Tourenne, RA Smith, J Ravits, AH Burghes, PJ Shaw, DW Cleveland, SJ Kolb, BK Kaspar. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. PNAS 2014 Jan 14;111(2):829-32.

  7. KD Foust *, DL Salazar *, S Likhite *, L Ferraiuolo*, D Ditsworth *, H Ilieva, K Meyer, L Schmelzer, L Braun, DW Cleveland, BK Kaspar.Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther. 2013 Dec;21(12):2148-59 *The first five authors contributed equally to this work.

  8. L Ferraiuolo, A Frakes, BK Kaspar. Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis. Mol Ther 2013 Mar;21(3):503-5. Commentary.

  9. L Ferraiuolo, A Higginbottom, PR Heath, S Barber, D Greenald, J Kirby, PJ Shaw. Dysregulation of astrocyte-motor neuron cross-talk in mSOD1 related amyotrophic lateral sclerosis. Brain 2011 Sep;134(Pt 9):2627-41.

  10. L Ferraiuolo, J Kirby, AJ Grierson, M Sendtner, PJ Shaw. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Rev Neurol 2011 Nov;7(11):616-30. Review.

Also see

http://www.researcherid.com/rid/E-5834-2010

https://www.researchgate.net/profile/Laura_Ferraiuolo

Professional Activities

Membership of societies and scientific communities

2012 - Society for Neuroscience, USA

2011 - Delegate for the ALS/MND Research and Care Community Blog

2008 - Biochemical Society, UK

2008 - British Society for Cell Biology, UK

Reviewer for several journals, including Brain and Glia

Reviewer for several funding bodies, including the Motor Neurone Disease Association (MNDA) and Action Medical Research

Biography

I studied Biotechnology at the University of Milan, Italy. During my degree I completed a 2-year internship at the Mario Negri Institute under the supervision of Dr Caterina Bendotti, where I developed a deep interest in motor neuron disease (MND).

In 2005 I joined the Department of Neuroscience at the University of Sheffield, UK, and won the MND Association Prize studentship that funded my PhD under the supervision of Professor Dame Pamela Shaw and Dr Janine Kirby. During my PhD I used laser capture microdissection and microarray analysis to interrogate the pathways involved in the response of motor neuron to stress, from expression of mutant SOD1 to intense exercise (Journal of Neuroscience 2007 and Journal of Neurochemistry 2009).

I was then awarded the Peake Fellowship to investigate the crosstalk between motor neurons and astrocytes in MND using microarray analysis and cellular models (Brain 2011) in Sheffield at the Institute for Translational Neuroscience. I had the great opportunity to deepen my knowledge on glia and gene therapy in Prof Kaspar’s lab in Columbus, Ohio, USA from 2012 to 2014 when I was awarded the prestigious International Outgoing Marie Curie Fellowship funded by the European Union. In Professor Kaspar’s lab I had the opportunity to contribute to the development of new cell models to study ALS in vitro (Neuron 2014 and PNAS 2014) and explore different routes of delivery for gene therapy clinical trials in MND (Molecular Therapy 2013) and spinal muscular atrophy (SMA) (Molecular Therapy 2014).

At the end of 2014 I came back to Sheffield to complete my Marie Curie Fellowship and I am now Lecturer in Translational Neurobiology in SITraN, where I am setting up my research group.

Contact Details

Academic Neurology Unit
Department of Neuroscience
Sheffield Institute for Translational Neuroscience
University of Sheffield
Room B36
385a Glossop Road
Sheffield
S10 2HQ

Tel: +44 (0)114 22 22257
Fax: +44 (0)114 22 22290
Email: l.ferraiuolo@shef.ac.uk